Figures & data
Table I. International Classification of Diseases for Oncology (ICD-O) codes for the analysed glioma groups.
Figure 1. Incidence of all glioma according to gender, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).
![Figure 1. Incidence of all glioma according to gender, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).](/cms/asset/b32e9978-8c11-4ce8-8490-8c17a80e48ed/ionc_a_154302_f0001_b.gif)
Figure 2. Incidence of all glioma according to gender and age, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).
![Figure 2. Incidence of all glioma according to gender and age, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).](/cms/asset/a59f3335-96b7-4919-bc6b-3fbb377c4fd4/ionc_a_154302_f0002_b.gif)
Table II. Total number of registered glioma patients in the Netherlands during the period 1989–2003, for diagnosis groups and age categories.
Figure 3. Incidence of astrocytic glioma and glioma of uncertain histology according to gender, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).
![Figure 3. Incidence of astrocytic glioma and glioma of uncertain histology according to gender, European Standardised Rates, 3-year moving average, with Estimated Annual Percentage Change (EAPC).](/cms/asset/37288ef4-a244-423c-830a-6851ab4eb8e4/ionc_a_154302_f0003_b.gif)